作者: Dave Cavanagh , Rosa Casais , Maria Armesto , Teri Hodgson , Sousan Izadkhasti
DOI: 10.1016/J.VACCINE.2007.02.046
关键词:
摘要: Infectious bronchitis coronavirus (IBV) is the cause of single most economically costly infectious disease domestic fowl in UK—and probably so many countries that have a developed poultry industry. A major reason for its continued dominance existence as serotypes, determined by surface spike protein (S), cross-protection being poor. Although controlled to some degree live and inactivated vaccines, new generation IB vaccines called for. Reverse genetic or ‘infectious clone’ systems, which allow manipulation IBV genome, are key this development. New would ideally be: genetically stable (i.e. maintain attenuated phenotype); administered ovo; be flexible with respect source gene. Rational attenuation requires identification genes simultaneously not essential replication whose absence reduce pathogenicity. Being able modify ‘core’ vaccine strain make it applicable prevailing serotype procedure doing so, demonstration ‘spike-swapping’ sufficient induce good immunity. We demonstrated four small proteins, encoded 3 5, replication; failure produce these proteins had little detrimental affect on titre virus produced. Our current molecularly cloned IBV, Beaudette, non-pathogenic, we do know what effect That said, plaque size composition various gene 3/5 recombinant IBVs cell culture, reduced output ciliostasis tracheal organ cultures, shows they less aggressive than wild-type Beaudette. Consequently remain targets rational attenuation. We recently obtained evidence one more 15 1 also determinants Hence target attenuation. Replacing S Beaudette from pathogenic M41 resulted was still non-pathogenic but did protection against challenge M41. since made other ‘spike-swapped’ recombinants, including ones chimaera genes. Uniquely, our molecular clone benign when 18-day-old embryos, even at high doses, induces immunity after route vaccination. Taken together, results point creation based modification realisable objective.